These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 3032651
1. (Na+,K+)-ATPase and noradrenergic function: effects of chronic ethanol. Swann AC. Eur J Pharmacol; 1987 Feb 10; 134(2):145-53. PubMed ID: 3032651 [Abstract] [Full Text] [Related]
2. Brain (Na+,K+)-ATPase and noradrenergic function: recovery of enzyme activity after norepinephrine depletion. Swann AC. Brain Res; 1984 Nov 12; 321(2):323-6. PubMed ID: 6093936 [Abstract] [Full Text] [Related]
3. (Na+, K+)-adenosine triphosphatase regulation by the sympathetic nervous system: effects of noradrenergic stimulation and lesions in vivo. Swann AC. J Pharmacol Exp Ther; 1984 Feb 12; 228(2):304-11. PubMed ID: 6141282 [Abstract] [Full Text] [Related]
4. Brain Na+,K+-ATPase: alteration of ligand affinities and conformation by chronic ethanol and noradrenergic stimulation in vivo. Swann AC. J Neurochem; 1986 Sep 12; 47(3):707-14. PubMed ID: 3016182 [Abstract] [Full Text] [Related]
5. (Na+,K+)-ATPase and noradrenergic regulation: effects of cardiac glycoside treatment and noradrenergic manipulations. Swann AC. Eur J Pharmacol; 1985 Dec 10; 119(1-2):67-74. PubMed ID: 3002819 [Abstract] [Full Text] [Related]
6. Norepinephrine and (Na+, K+)-ATPase: evidence for stabilization by lithium or imipramine. Swann AC. Neuropharmacology; 1988 Mar 10; 27(3):261-7. PubMed ID: 2836750 [Abstract] [Full Text] [Related]
7. Dexamethasone and adrenalectomy alter brain (Na+,K+)-ATPase responses to noradrenergic stimulation or depletion. Swann AC. Eur J Pharmacol; 1988 Dec 06; 158(1-2):43-52. PubMed ID: 2851459 [Abstract] [Full Text] [Related]
8. Subacute noradrenergic agonist infusions in vivo increase Na+, K+-ATPase and ouabain binding in rat cerebral cortex. Swann AC, Steketee JD. J Neurochem; 1989 May 06; 52(5):1598-604. PubMed ID: 2540278 [Abstract] [Full Text] [Related]
9. Noradrenaline and thyroid function regulate (Na+,K+)-adenosine triphosphatase independently in vivo. Swann AC. Eur J Pharmacol; 1989 Oct 10; 169(2-3):275-83. PubMed ID: 2553449 [Abstract] [Full Text] [Related]
10. Stimulation of brain Na+, K+-ATPase by norepinephrine in vivo: prevention by receptor antagonists and enhancement by repeated stimulation. Swann AC. Brain Res; 1983 Feb 07; 260(2):338-41. PubMed ID: 6299462 [Abstract] [Full Text] [Related]
11. Na+,K(+)-ATPase activity in CNS and noradrenergic neurotransmission: time course of differential desipramine (DMI) effects. Viola MS, Rodríguez de Lores Arnaiz G, Enero MA. Neurochem Int; 1994 Jan 07; 24(1):91-7. PubMed ID: 8130740 [Abstract] [Full Text] [Related]
12. Brain (Na+, K+)-ATPase and noradrenergic activity: effects of hyperinnervation and denervation on high-affinity ouabain binding. Swann AC, Grant SJ, Maas JW. J Neurochem; 1982 Mar 07; 38(3):836-9. PubMed ID: 6173466 [Abstract] [Full Text] [Related]
13. Isoform-specific regulation of myocardial Na,K-ATPase alpha-subunit in congestive heart failure. Role of norepinephrine. Kim CH, Fan TH, Kelly PF, Himura Y, Delehanty JM, Hang CL, Liang CS. Circulation; 1994 Jan 07; 89(1):313-20. PubMed ID: 8281663 [Abstract] [Full Text] [Related]
14. Ouabain binding to brain (Na+,K+)-adenosine triphosphatase: interactions of K+, ethanol and norepinephrine with high- and low-affinity binding. Swann AC. J Pharmacol Exp Ther; 1987 Jan 07; 240(1):187-95. PubMed ID: 3027303 [Abstract] [Full Text] [Related]
15. Caloric intake and Na+-K+-ATPase: differential regulation by alpha 1- and beta-noradrenergic receptors. Swann AC. Am J Physiol; 1984 Sep 07; 247(3 Pt 2):R449-55. PubMed ID: 6089594 [Abstract] [Full Text] [Related]
16. (Na+, K+)-ATPase regulation and NaCl intake: effects on circulating inhibitor and sensitivity to noradrenaline. Swann AC. Clin Sci (Lond); 1985 Oct 07; 69(4):441-7. PubMed ID: 2994940 [Abstract] [Full Text] [Related]
17. Stimulation of synaptosomal Na+,K(+)-ATPase by ethanol: possible involvement of an isozyme-specific inhibitor of Na+,K(+)-ATPase. Foley TD, Rhoads DE. Brain Res; 1994 Aug 08; 653(1-2):167-72. PubMed ID: 7982050 [Abstract] [Full Text] [Related]
18. [N-2-chloroethyl-N-ethyl-2-bromobenzylamine (DSP4) increases the liberation of 3H-noradrenaline produced by depolarization of the nerve ending]. Landa ME, Rubio MC, Jaim-Etcheverry G. Acta Physiol Pharmacol Latinoam; 1988 Aug 08; 38(2):167-80. PubMed ID: 2847491 [Abstract] [Full Text] [Related]
19. Ethanol-induced inhibition of mouse brain adenosine triphosphatase activities: lack of interaction with norepinephrine in vitro. Syapin PJ, Alkana RL. Alcohol Clin Exp Res; 1986 Dec 08; 10(6):635-40. PubMed ID: 3028199 [Abstract] [Full Text] [Related]
20. Altered hindlimb extension in the rat after DSP-4: a useful marker of central noradrenergic depletion. Mogilnicka E, Dooley DJ, Boissard CG, Delini-Stula A. Eur J Pharmacol; 1983 Feb 18; 87(2-3):345-7. PubMed ID: 6840195 [Abstract] [Full Text] [Related] Page: [Next] [New Search]